Position in ALKS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$210,851
+$36,732 QoQ
Shares Held
5,963
-4.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CENTAURUS FINANCIAL, INC. holds $2,456,588 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,227 | $1,211,637 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
6,621 | $502,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,507 | $296,352 | |
| 4 | ALKS |
Alkermes plc.
This page
|
5,963 | $210,851 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
6,377 | $152,601 | |
| 6 | TLRY |
Tilray Brands, Inc.
|
12,820 | $82,945 |
All Filings in ALKS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $210,851 | 5,963 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $174,119 | 6,223 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $168,060 | 5,602 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $132,807 | 4,642 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $153,278 | 4,642 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,227,275 | 42,673 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $1,196,628 | 42,752 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $935,803 | 38,830 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $1,044,739 | 38,594 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||